XML 157 R136.htm IDEA: XBRL DOCUMENT v3.3.1.900
Schedule II. Condensed Financial Information Of Registrant (Statements of Cash Flows) (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May. 31, 2013
Dec. 31, 2006
Mar. 31, 2004
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows provided by (used in) operating activities:                            
Net income attributable to RenaissanceRe       $ 97,801,000 $ 81,124,000 $ 78,829,000 $ 173,438,000 $ 176,362,000 $ 73,410,000 $ 126,348,000 $ 156,598,000 $ 431,192,000 $ 532,718,000 $ 690,624,000
Less: equity in net income of subsidiaries                       0 0 0
Adjustments to reconcile net income to net cash provided by operating activities                            
Net unrealized losses (gains) included in net investment income                       13,549,000 1,393,000 (75,789,000)
Net unrealized gains included in other income (loss)                       426,000 1,612,000 12,782,000
Net realized and unrealized losses (gains) on investments       42,817,000 $ 41,138,000 $ 26,712,000 (41,749,000) (30,475,000) $ 31,097,000 $ (27,128,000) (14,927,000) 68,918,000 (41,433,000) (35,076,000)
Other                       2,892,000 (71,146,000) 159,892,000
Net cash provided by operating activities                       414,737,000 660,657,000 795,721,000
Cash flows provided by (used in) investing activities                            
Proceeds from maturities and sales of fixed maturity investments trading                       9,481,742,000 7,682,573,000 8,251,405,000
Purchases of fixed maturity investments trading                       (9,683,068,000) (7,639,178,000) (8,466,467,000)
Net (purchases) sales of short term investments                       669,116,000 45,023,000 (246,971,000)
Dividends and return of capital from subsidiaries                       0 0 0
Contributions to subsidiaries                       0 0 0
Net purchase of Platinum                       (678,152,000) 0 0
Net cash (used in) provided by investing activities                       (339,039,000) 141,653,000 (315,515,000)
Cash flows used in financing activities                            
Dividends paid – RenaissanceRe common shares                       (53,967,000) (45,912,000) (49,267,000)
Dividends paid – preference shares                       (22,381,000) (22,381,000) (24,948,000)
RenaissanceRe common share repurchases                       (259,874,000) (514,678,000) (207,410,000)
Repayment of debt                           (102,436,000)
Net cash used in financing activities                       (83,665,000) (694,678,000) (398,955,000)
Net increase (decrease) in cash and cash equivalents                       (18,699,000) 117,552,000 82,674,000
Cash and cash equivalents, beginning of period             525,584,000       408,032,000 525,584,000 408,032,000 304,145,000
Cash and cash equivalents, end of period       506,885,000       525,584,000       506,885,000 525,584,000 408,032,000
Series C Preferred Stock                            
Cash flows used in financing activities                            
Redemption of preference shares                       0 0 (125,000,000)
Issuance of 5.375% Series E preference shares, net of expenses     $ 250,000,000                      
Series D Preferred Stock                            
Cash flows used in financing activities                            
Redemption of preference shares                       0 0 (150,000,000)
Issuance of 5.375% Series E preference shares, net of expenses   $ 300,000,000                        
Series E Preferred Stock                            
Cash flows used in financing activities                            
Issuance of 5.375% Series E preference shares, net of expenses $ 275,000,000                     0 0 265,856,000
Parent Company                            
Cash flows provided by (used in) operating activities:                            
Net income attributable to RenaissanceRe                       431,192,000 532,718,000 690,624,000
Less: equity in net income of subsidiaries                       (463,526,000) (545,839,000) (713,831,000)
Loss before equity in net income of subsidiaries                       (32,334,000) (13,121,000) (23,207,000)
Adjustments to reconcile net income to net cash provided by operating activities                            
Net unrealized gains included in other income (loss)                       0 0 (20,000)
Net realized and unrealized losses (gains) on investments                       2,080,000 (83,000) 483,000
Other                       (8,959,000) 13,633,000 (13,764,000)
Net cash provided by operating activities                       (39,213,000) 429,000 (36,508,000)
Cash flows provided by (used in) investing activities                            
Proceeds from maturities and sales of fixed maturity investments trading                       63,824,000 88,273,000 880,749,000
Purchases of fixed maturity investments trading                       (161,183,000) (88,341,000) (491,768,000)
Net (purchases) sales of short term investments                       (116,461,000) 73,717,000 21,217,000
Dividends and return of capital from subsidiaries                       1,584,624,000 1,259,224,000 504,241,000
Contributions to subsidiaries                       (294,733,000) (759,456,000) (500,652,000)
Due to (from) subsidiary                       207,996,000 6,315,000 15,988,000
Net purchase of Platinum                       (904,433,000) 0 0
Net cash (used in) provided by investing activities                       379,634,000 579,732,000 429,775,000
Cash flows used in financing activities                            
Dividends paid – RenaissanceRe common shares                       (53,967,000) (45,912,000) (49,267,000)
Dividends paid – preference shares                       (22,381,000) (22,381,000) (24,948,000)
RenaissanceRe common share repurchases                       (259,874,000) (514,678,000) (207,410,000)
Repayment of debt                       0 0 (100,000,000)
Net cash used in financing activities                       (336,222,000) (582,971,000) (390,769,000)
Net increase (decrease) in cash and cash equivalents                       4,199,000 (2,810,000) 2,498,000
Cash and cash equivalents, beginning of period             $ 5,986,000       $ 8,796,000 5,986,000 8,796,000 6,298,000
Cash and cash equivalents, end of period       $ 10,185,000       $ 5,986,000       10,185,000 5,986,000 8,796,000
Parent Company | Series C Preferred Stock                            
Cash flows used in financing activities                            
Redemption of preference shares                       0 0 (125,000,000)
Parent Company | Series D Preferred Stock                            
Cash flows used in financing activities                            
Redemption of preference shares                       0 0 (150,000,000)
Parent Company | Series E Preferred Stock                            
Cash flows used in financing activities                            
Issuance of 5.375% Series E preference shares, net of expenses                       $ 0 $ 0 $ 265,856,000